{
    "pmcid": "10883280",
    "qa_pairs": {
        "How does AlphaFold-Multimer's sensitivity change with protein fragment length?": [
            "Sensitivity decreases significantly with longer protein fragments or full-length proteins",
            "Sensitivity increases with longer protein fragments or full-length proteins",
            "Sensitivity remains constant regardless of protein fragment length",
            "Sensitivity is not affected by protein fragment length"
        ],
        "How many novel interfaces were experimentally validated in the study?": [
            "Six novel interfaces",
            "Ten novel interfaces",
            "Four novel interfaces",
            "Eight novel interfaces"
        ],
        "What is a key application of the study's insights in the context of SARS-CoV-2?": [
            "Designing nanobody binders to the SARS-CoV-2 spike protein",
            "Developing vaccines targeting the SARS-CoV-2 nucleocapsid protein",
            "Creating antiviral drugs that inhibit SARS-CoV-2 RNA replication",
            "Engineering spike protein mutations to study viral infectivity"
        ],
        "What is the main focus of AlphaFold-Multimer in predicting protein-protein interaction interfaces?": [
            "Domain-motif interactions and domain-domain interactions",
            "Protein-ligand interactions and enzyme-substrate interactions",
            "Membrane protein interactions and cytoskeletal protein interactions",
            "Transcription factor-DNA interactions and RNA-protein interactions"
        ],
        "What strategy was developed to enhance sensitivity for predicting domain-motif interfaces?": [
            "A protein fragmentation strategy",
            "A full-length protein analysis strategy",
            "A motif exclusion strategy",
            "A domain expansion strategy"
        ]
    }
}